Xavier Leleu
2001–2026 年に発表
- 218
- 論文数
- 35,836
- 被引用数
- 94
- h 指数
- 204
- i10 指数
被引用数
引用元
国・地域
機関
分野
- Medicine74.5%
- Biochemistry, Genetics and Molecular Biology19.9%
- Immunology and Microbiology3.9%
- Engineering0.3%
- Computer Science0.3%
- Pharmacology, Toxicology and Pharmaceutics0.2%
- その他0.9%
トピック
- Multiple Myeloma Research and Treatments19.6%
- Protein Degradation and Inhibitors8.8%
- Peptidase Inhibition and Analysis4.7%
- CAR-T cell therapy research3.9%
- Chronic Lymphocytic Leukemia Research2.9%
- Ubiquitin and proteasome pathways2.7%
- その他57.4%
共著者
- Philippe Moreau95
- Cyrille Hulin61
- Thierry Façon61
- Aurore Perrot58
- Meletios Α. Dimopoulos51
- Margaret Macro48
- Hervé Avet‐Loiseau41
- Lionel Karlin41
- Salomon Manier36
- Mohamad Mohty34
- María‐Victoria Mateos32
- Michèle Cavo32
- Denis Caillot31
- Katja Weisel31
- Kenneth C. Anderson30
- Jill Corre29
- Laurent Garderet29
- Murielle Roussel29
- Roman Hájek29
- Paul G. Richardson26
- Cyrille Touzeau25
- Hang Quach25
- Karim Belhadj25
- Michel Attal25
全論文
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
著者: S. Vincent Rajkumar, Meletios Α. Dimopoulos, Antonio Palumbo, Joan Bladé, Giampaolo Merlini, María‐Victoria Mateos, Shaji Kumar, Jens Hillengaß, Efstathios Kastritis, Paul G. Richardson, Ola Landgren, Bruno Paiva, Angela Dispenzieri, Brendan M. Weiss, Xavier Leleu, Sonja Zweegman, Sagar Lonial, Laura Rosiñol, Elena Zamagni, Sundar Jagannath, Orhan Sezer, Sigurður Y. Kristinsson, Jo Caers, Saad Z. Usmani, Juan José Lahuerta, Hans Erik Johnsen, Meral Beksaç, Michèle Cavo, Hartmut Goldschmidt, Evangelos Terpos, Robert A. Kyle, Kenneth C. Anderson, Brian G.M. Durie, Jesús F. San Miguel - The Lancet Oncology 2014 被引用: 4,869
- Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
著者: Jesús F. San Miguel, Binod Dhakal, Kwee Yong, Andrew Spencer, Sébastien Anguille, María‐Victoria Mateos, Carlos Fernández de Larrea, Joaquín Martínez‐López, Philippe Moreau, Cyrille Touzeau, Xavier Leleu, Irit Avivi, Michèle Cavo, Tadao Ishida, Seok Jin Kim, Wilfried Roeloffzen, Niels W.C.J. van de Donk, Dominik Dytfeld, Surbhi Sidana, Luciano J. Costa, Albert Oriol, Rakesh Popat, Abdullah Khan, Yaël C. Cohen, P. Joy Ho, James E. Griffin, Nikoletta Lendvai, Carolina Lonardi, Ana Slaughter, Jordan M. Schecter, Carolyn C. Jackson, Kaitlyn Connors, Katherine Li, Enrique Zudaire, Diana Chen, Jane Gilbert, Tzu‐Min Yeh, Sarah Nagle, Erika Florendo, Lida Pacaud, Nitin Patel, Simon J. Harrison, Hermann Einsele - New England Journal of Medicine 2023 被引用: 733
- Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
著者: Pieter Sonneveld, Meletios Α. Dimopoulos, Mario Boccadoro, Hang Quach, P. Joy Ho, Meral Beksaç, Cyrille Hulin, Elisabetta Antonioli, Xavier Leleu, Silvia Mangiacavalli, Aurore Perrot, Michèle Cavo, Angelo Belotti, Annemiek Broijl, Francesca Gay, Roberto Mina, Inger S. Nijhof, Niels W.C.J. van de Donk, Eirini Katodritou, Fredrik Schjesvold, Anna Sureda, Laura Rosiñol, Michel Delforge, Wilfried Roeloffzen, Tobias Silzle, Annette Juul Vangsted, Hermann Einsele, Andrew Spencer, Roman Hájek, Artur Jurczyszyn, Sarah Lonergan, Tahamtan Ahmadi, Yanfang Liu, Jianping Wang, Diego Vieyra, Emilie M.J. van Brummelen, Véronique Vanquickelberghe, Anna Sitthi-Amorn, Carla J. de Boer, Robin Carson, Paula Rodríguez‐Otero, Joan Bladé, Philippe Moreau - New England Journal of Medicine 2023 被引用: 515
- Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study
著者: Philippe Moreau, Michel Attal, Cyrille Hulin, Bertrand Arnulf, Karim Belhadj, Lotfi Benboubker, Marie C. Béné, Annemiek Broijl, Hélène Caillon, Denis Caillot, Jill Corre, Michel Delforge, Thomas Dejoie, Chantal Doyen, Thierry Façon, Cécile Sonntag, Jean Fontan, Laurent Garderet, Kon‐Siong G. Jie, Lionel Karlin, Frédérique Kuhnowski, Jérôme Lambert, Xavier Leleu, Pascal Lenain, Margaret Macro, Claire Mathiot, Frédérique Orsini‐Piocelle, Aurore Perrot, Anne‐Marie Stoppa, Niels W.C.J. van de Donk, Soraya Wuillème, Sonja Zweegman, Brigitte Kolb, Cyrille Touzeau, Murielle Roussel, Mourad Tiab, Jean‐Pierre Marolleau, Nathalie Meuleman, Marie‐Christiane Vekemans, Matthijs Westerman, Saskia K. Klein, Mark‐David Levin, Jean Paul Fermand, Martine Escoffre‐Barbe, Jean‐Richard Eveillard, Réda Garidi, Tahamtan Ahmadi, Sen Hong Zhuang, Christopher Chiu, Lixia Pei, Carla de Boer, Elena Smith, William Deraedt, Tobias Kampfenkel, Jordan M. Schecter, Jessica Vermeulen, Hervé Avet‐Loiseau, Pieter Sonneveld - The Lancet 2019 被引用: 953
- Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma
著者: Michel Attal, Valérie Lauwers‐Cancès, Cyrille Hulin, Xavier Leleu, Denis Caillot, Martine Escoffre, Bertrand Arnulf, Margaret Macro, Karim Belhadj, Laurent Garderet, Murielle Roussel, Catherine Payen, Claire Mathiot, Jean Paul Fermand, Nathalie Meuleman, Sandrine Rollet, Michelle E. Maglio, Andrea A. Zeytoonjian, Edie Weller, Nikhil C. Munshi, Kenneth C. Anderson, Paul G. Richardson, Thierry Façon, Hervé Avet‐Loiseau, Jean‐Luc Harousseau, Philippe Moreau - New England Journal of Medicine 2017 被引用: 1,234
- Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma
著者: Thierry Façon, Shaji Kumar, Torben Plesner, Robert Z. Orlowski, Philippe Moreau, Nizar J. Bahlis, Supratik Basu, Hareth Nahi, Cyrille Hulin, Hang Quach, Hartmut Goldschmidt, Michael O’Dwyer, Aurore Perrot, Christopher P. Venner, Katja Weisel, Joseph R. Mace, Noopur Raje, Michel Attal, Mourad Tiab, Margaret Macro, Laurent Frenzel, Xavier Leleu, Tahamtan Ahmadi, Christopher Chiu, Jianping Wang, Rian Van Rampelbergh, Clarissa Uhlar, Rachel Kobos, Ming Qi, Saad Z. Usmani - New England Journal of Medicine 2019 被引用: 987
- Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
著者: Philippe Moreau, Meletios Α. Dimopoulos, Joseph Mıkhael, Kwee Yong, Marcelo Capra, Thierry Façon, Roman Hájek, Ivan Špıčka, Ross Baker, Kihyun Kım, Gracia Martınez, Chang‐Ki Min, Luděk Pour, Xavier Leleu, Albert Oriol, Youngil Koh, Kenshi Suzuki, Marie‐Laure Risse, Gaëlle Asset, Sandrine Macé, Thomas G. Martin, Philippe Moreau, Meletios Α. Dimopoulos, Joseph Mıkhael, Kwee Yong, Marcelo Capra, Thierry Façon, Roman Hájek, Ivan Špıčka, Ross Baker, Kim Kihyun, Gracia Martınez, Min Chang‐Ki, Luděk Pour, Xavier Leleu, Albert Oriol, Koh Youngil, Kenshi Suzuki, Tom Martin, Hang Quach, Andrew Lim, Helen Crowther, Hanlon Sia, Cyrille Hulin, Mohamad Mohty, Gábor Mikala, Zsolt Nagy, Marta Reinoso Segura, Laura Rosiñol, Münci Yağcı, Mehmet Turgut, Mamta Garg, Gurdeep Parmar, Brad Augustson, Nelson Castro, Edvan de Queiroz Crusoé, Tomáš Pika, Sosana Delimpasi, Kenichi Ishizawa, Anup George, Т. С. Константинова, Javier de la Rubia, Kim Sung-Hyun, Ângelo Maiolino, Tony Reiman, Richard LeBlanc, Shigeki Ito, Junji Tanaka, А. С. Лучинин, I. V. Kryuchkova, Joaquín Martínez‐López, Jesse Shustik, Lionel Karlin, Anargyros Symeonidis, Miklós Egyed, Mario Petrini, Michèle Cavo, Michihiro Uchiyama, Hilary Blacklock, Mutlu Arat, James E. Griffin, Hannah Hunter, Tonda Buck, Αchilles Anagnostopoulos, Κωνσταντίνος Κωνσταντόπουλος, Tamás Masszi, Sara Bringhen, Barbara Gamberi, Yawara Kawano, Kim Jin Seok, Hakan Özdoğu, Fahir Özkalemkaş - The Lancet 2021 被引用: 380
- Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial
著者: Thierry Façon, Shaji Kumar, Torben Plesner, Robert Z. Orlowski, Philippe Moreau, Nizar J. Bahlis, Supratik Basu, Hareth Nahi, Cyrille Hulin, Hang Quach, Hartmut Goldschmidt, Michael O’Dwyer, Aurore Perrot, Christopher P. Venner, Katja Weisel, Joseph R. Mace, Noopur Raje, Mourad Tiab, Margaret Macro, Laurent Frenzel, Xavier Leleu, Tahamtan Ahmadi, Jianping Wang, Rian Van Rampelbergh, Clarissa Uhlar, Brenda Tromp, Maria Delioukina, Jessica Vermeulen, Saad Z. Usmani - The Lancet Oncology 2021 被引用: 363
- Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study
著者: Michel Attal, Paul G. Richardson, S. Vincent Rajkumar, Jesús F. San Miguel, Meral Beksaç, Ivan Špıčka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios Α. Dimopoulos, Jeffrey Shang-Yi Huang, Jiří Minařík, Michèle Cavo, H. Miles Prince, Sandrine Macé, Kathryn P. Corzo, Frank Campana, Solenn Le-Guennec, Franck Dubin, Kenneth C. Anderson, Michel Attal, Paul G. Richardson, S. Vincent Rajkumar, Jesús F. San Miguel, Meral Beksaç, Ivan Špıčka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios Α. Dimopoulos, Jeffrey Shang-Yi Huang, Jiří Minařík, Michèle Cavo, H. Miles Prince, Sandrine Macé, Kathryn P. Corzo, Frank Campana, Solenn Le-Guennec, Franck Dubin, Kenneth C. Anderson, Simon J. Harrison, Wojciech Janowski, Ian Kerridge, Andrew Spencer, Michel Delforge, Karel Fostier, Philip Vlummens, Ka Lung Wu, Richard LeBlanc, Michel Pavic, Michaël Sébag, Roman Hájek, Vladimír Maisnar, Luděk Pour, Henrik Gregersen, Lotfi Benbouker, Denis Caillot, Martine Escoffre‐Barbe, Thierry Façon, Laurent Frenzel, Cyrille Hulin, Lionel Karlin, Brigitte Kolb, Brigitte Pegourié, Aurore Perrot, Mourad Tiab, Laure Vincent, Dietger Niederwieser, Αchilles Anagnostopoulos, Sosana Delimpasi, Marie‐Christine Kyrtsonis, Anargyros Symeonidis, Árpád Illés, Gábor Mikala, Zsolt Nagy, Sara Bringen, Paolo Corradini, Fabio Ciceri, Roberto M. Lemoli, Anna Marina Liberati, Chiara Nozzoli, Renato Zambello, Shinsuke Iida, Takashi Ikeda, Satoshi Iyama, Morio Matsumoto, Chihiro Shimazaki, Kazutaka Sunami, Kenshi Suzuki, Michihiro Uchiyama, Youngil Koh, Kihyun Kım, Jae Hoon Lee, Chang‐Ki Min, Hillary Blacklock, Hugh J. B. Goodman, Annette Neylon, David Simpson, Sebastian Grosicki, Artur Jurczyszyn ほか 30 名 - The Lancet 2019 被引用: 636
- Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
著者: Meletios Α. Dimopoulos, Evangelos Terpos, Mario Boccadoro, Sosana Delimpasi, Meral Beksaç, Eirini Katodritou, Philippe Moreau, Luca Baldini, Argiris Symeonidis, Jelena Bila, Albert Oriol, María‐Victoria Mateos, Hermann Einsele, Ioannis Orfanidis, Tahamtan Ahmadi, Jon Ukropec, Tobias Kampfenkel, Jordan M. Schecter, Yanping Qiu, Himal Amin, Jessica Vermeulen, Robin Carson, Pieter Sonneveld, Adrián Alegre Amor, Luca Baldini, Meral Beksaç, Angelo Belotti, Lotfi Benboubker, Britta Besemer, Sevgi Kalayoğlu Beşışık, Jelena Bila, Mario Boccadoro, Michèle Cavo, Javier de la Rubia Comos, Sosana Delimpasi, Meletios Α. Dimopoulos, Chantal Doyen, Dominik Dytfeld, Monika Engelhardt, Thierry Façon, Roberto Foà, Hartmut Goldschmidt, Sebastian Grosicki, Roman Hájek, Güner Hayri Özsan, Cyrille Hulin, Brian Iversen, Lionel Karlin, Eirini Katodritou, Stefan Knop, Marie‐Christine Kyrtsonis, Juan José Lahuerta, Xavier Leleu, Carmen Martínez Chamorro, María-Victoria Mateos Manteca, Nathalie Meuleman, Monique C. Minnema, Philippe Moreau, Massino Offidani, Albert Oriol Rocafiguera, Mustafa Pehlıvan, Luděk Pour, Henk Roerdink, Laura Rosinol Dacsh, Hans Salwender, Pieter Sonneveld, Anargyros Symeonidis, Charlotte Toftmann Hansen, Tülin Tuğlular, Ali Ünal, Philip Vlummens, Filiz Vural, Ka Lung Wu, Sonja Zweegman - The Lancet Oncology 2021 被引用: 327
- Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study
著者: Meletios Α. Dimopoulos, Vânia Hungria, Atanas Radinoff, Sosana Delimpasi, Gábor Mikala, Tamás Masszi, Li J, Marcelo Capra, Ângelo Maiolino, Vasiliki Pappa, Dominik Chraniuk, Iurii Osipov, Xavier Leleu, Michael Löw, Morio Matsumoto, Neal Sule, Mary Li, Astrid McKeown, Wei He, Shelley Bright, Brooke M. Currie, Sue Perera, Julia Boyle, Sumita Roy–Ghanta, Joanna Opalińska, Katja Weisel - The Lancet Haematology 2023 被引用: 124
- International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
著者: María‐Victoria Mateos, Shaji Kumar, Meletios Α. Dimopoulos, Verónica González‐Calle, Efstathios Kastritis, Roman Hájek, Carlos Fernández de Larrea, Gareth J. Morgan, Giampaolo Merlini, Hartmut Goldschmidt, Catarina Geraldes, Alessandro Gozzetti, Charalampia Kyriakou, Laurent Garderet, Markus Hansson, Elena Zamagni, Dorotea Fantl, Xavier Leleu, Byung‐Su Kim, Graça Esteves, Heinz Ludwig, Saad Z. Usmani, Chang‐Ki Min, Ming Qi, Jon Ukropec, Brendan M. Weiss, S. Vincent Rajkumar, Brian G.M. Durie, Jesús F. San Miguel - Blood Cancer Journal 2020 被引用: 275
- Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma
著者: Aurore Perrot, Valérie Lauwers‐Cancès, Jill Corre, Nelly Robillard, Cyrille Hulin, Marie‐Lorraine Chrétien, Thomas Dejoie, Sabrina Mahéo, Anne-Marie Stoppa, Brigitte Pegourié, Lionel Karlin, Laurent Garderet, Bertrand Arnulf, Chantal Doyen, Nathalie Meuleman, Bruno Royer, Jean‐Richard Eveillard, Lotfi Benboubker, Mamoun Dib, Olivier Decaux, Arnaud Jaccard, Karim Belhadj, Sabine Bréchignac, Brigitte Kolb, Cécile Fohrer, Mohamad Mohty, Margaret Macro, Paul G. Richardson, Victoria Carlton, Martin Moorhead, Tom Willis, Malek Faham, Kenneth C. Anderson, Jean‐Luc Harousseau, Xavier Leleu, Thierry Façon, Philippe Moreau, Michel Attal, Hervé Avet‐Loiseau, Nikhil C. Munshi - Blood 2018 被引用: 420
- Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial
著者: Sebastian Grosicki, Maryana Simonova, Ivan Špıčka, Luděk Pour, Iryrna Kriachok, Maria Gavriatopoulou, Halyna Pylypenko, Holger W. Auner, Xavier Leleu, Vadim Doronin, Ganna Usenko, Nizar J. Bahlis, Roman Hájek, Reuben Benjamin, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Christopher P. Venner, Mamta Garg, Mercedes Gironella, Artur Jurczyszyn, Paweł Robak, Mónica Galli, Craig T. Wallington‐Beddoe, Atanas Radinoff, Galina Salogub, Don A. Stevens, Supratik Basu, Anna Marina Liberati, Hang Quach, Vesselina Goranova‐Marinova, Jelena Bila, Eirini Katodritou, Hanna Oliynyk, Sybiryna Korenkova, Jeevan Kumar, Sundar Jagannath, Philippe Moreau, Moshe Levy, Darrell White, Moshe E. Gatt, Thierry Façon, María‐Victoria Mateos, Michèle Cavo, Donna Reece, Larry D. Anderson, Jean-Richard Saint-Martin, Jacqueline Jeha, Anita Joshi, Yi Chai, Lingling Li, Vishnuvardhan Peddagali, Melina Arazy, Jatin J. Shah, Sharon Shacham, Michael Kauffman, Meletios Α. Dimopoulos, Paul G. Richardson, Sosana Delimpasi - The Lancet 2020 被引用: 324
- Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma
著者: Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Alex Murison, Dil Begum, Nasrin M. Dahir, Paula Proszek, David C. Johnson, Martin Kaiser, Lorenzo Melchor, Lauren I. Aronson, Matthew Scales, Charlotte Pawlyn, Fabio Mirabella, John R Jones, Annamaria Brioli, Aneta Mikulášová, David A. Cairns, Walter M. Gregory, Ana Quartilho, Mark T. Drayson, Nigel H. Russell, Gordon Cook, Graham Jackson, Xavier Leleu, Faith E. Davies, Gareth J. Morgan - Journal of Clinical Oncology 2015 被引用: 564
- Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
著者: Philippe Moreau, Shaji Kumar, Jesús F. San Miguel, Faith E. Davies, Elena Zamagni, Nizar J. Bahlis, Heinz Ludwig, Joseph Mıkhael, Evangelos Terpos, Fredrik Schjesvold, Thomas G. Martin, Kwee Yong, Brian G.M. Durie, Thierry Façon, Artur Jurczyszyn, Surbhi Sidana, Noopur Raje, Niels W.C.J. van de Donk, Sagar Lonial, Michèle Cavo, Sigurður Y. Kristinsson, Suzanne Lentzsch, Roman Hájek, Kenneth C. Anderson, Cristina João, Hermann Einsele, Pieter Sonneveld, Monika Engelhardt, Rafaël Fonseca, Annette Juul Vangsted, Katja Weisel, Rachid Baz, Vânia Hungria, Jesús G. Berdeja, Fernando Leal da Costa, Ângelo Maiolino, Anders Waage, David H. Vesole, Enrique M. Ocio, Hang Quach, Christoph Driessen, Joan Bladé, Xavier Leleu, Eloísa Riva, P. Leif Bergsagel, Jian Hou, Wee Joo Chng, Ulf‐Henrik Mellqvist, Dominik Dytfeld, Jean‐Luc Harousseau, Hartmut Goldschmidt, Jacob P. Laubach, Nikhil C. Munshi, Francesca Gay, Meral Beksaç, Luciano J. Costa, Martin Kaiser, Parameswaran Hari, Mario Boccadoro, Saad Z. Usmani, Sonja Zweegman, Sarah A. Holstein, Orhan Sezer, Simon J. Harrison, Hareth Nahi, Gordon Cook, María‐Victoria Mateos, S. Vincent Rajkumar, Meletios Α. Dimopoulos, Paul G. Richardson - The Lancet Oncology 2021 被引用: 268
- Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study
著者: Thomas G. Martin, Meletios Α. Dimopoulos, Joseph Mıkhael, Kwee Yong, Marcelo Capra, Thierry Façon, Roman Hájek, Ivan Špıčka, Ross Baker, Kihyun Kım, Gracia Martınez, Chang‐Ki Min, Luděk Pour, Xavier Leleu, Albert Oriol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie‐Laure Risse, Philippe Moreau - Blood Cancer Journal 2023 被引用: 95
- International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
著者: Paula Rodríguez‐Otero, Saad Z. Usmani, Adam D. Cohen, Niels W.C.J. van de Donk, Xavier Leleu, Jaime Gállego Pérez‐Larraya, Salomon Manier, Ajay K. Nooka, María‐Victoria Mateos, Hermann Einsele, Monique C. Minnema, Michèle Cavo, Benjamin A. Derman, Noemí Puig, Francesca Gay, P. Joy Ho, Wee Joo Chng, Efstathios Kastritis, Gösta Gahrton, Katja Weisel, Chandramouli Nagarajan, Fredik Schjesvold, Joseph Mıkhael, Luciano J. Costa, Noopur Raje, Elena Zamagni, Roman Hájek, Niels Weinhold, Kwee Yong, Jing Christine Ye, Surbhi Sidana, Giampaolo Merlini, Tom Martin, Yi Lin, Ajai Chari, Rakesh Popat, Jonathan L. Kaufman - The Lancet Oncology 2024 被引用: 119
- Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Final Overall Survival Analysis From the Randomized Phase II ELOQUENT-3 Trial
著者: Meletios Α. Dimopoulos, Dominik Dytfeld, Sebastian Grosicki, Philippe Moreau, Naoki Takezako, Mitsuo Hori, Xavier Leleu, Richard LeBlanc, Kenshi Suzuki, Marc S. Raab, Paul G. Richardson, Mihaela Popa McKiver, Ying‐Ming Jou, David Yao, Prianka Das, Jesús F. San Miguel - Journal of Clinical Oncology 2022 被引用: 110
- Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma
著者: Aurore Perrot, Valérie Lauwers‐Cancès, Elodie Tournay, Cyrille Hulin, Marie‐Lorraine Chrétien, Bruno Royer, Mamoun Dib, Olivier Decaux, Arnaud Jaccard, Karim Belhadj, Sabine Bréchignac, Jean Fontan, Laurent Voillat, Hélène Demarquette, Philippe Collet, Philippe Rodon, Claudine Sohn, François Lifermann, Frédérique Orsini‐Piocelle, Valentine Richez, Mohamad Mohty, Margaret Macro, Stéphane Minvielle, Philippe Moreau, Xavier Leleu, Thierry Façon, Michel Attal, Hervé Avet‐Loiseau, Jill Corre - Journal of Clinical Oncology 2019 被引用: 179
- Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 study
著者: Meletios Α. Dimopoulos, Hang Quach, María‐Victoria Mateos, Ola Landgren, Xavier Leleu, David S. Siegel, Katja Weisel, Hui Yang, Zandra Klippel, Anita Zahlten‐Kumeli, Saad Z. Usmani - The Lancet 2020 被引用: 422
- Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial
著者: Philippe Moreau, Cyrille Hulin, Aurore Perrot, Bertrand Arnulf, Karim Belhadj, Lotfi Benboubker, Marie C. Béné, Sonja Zweegman, Hélène Caillon, Denis Caillot, Jill Corre, Michel Delforge, Thomas Dejoie, Chantal Doyen, Thierry Façon, Cécile Sonntag, Jean Fontan, Mohamad Mohty, Kon‐Siong G. Jie, Lionel Karlin, Frédérique Kuhnowski, Jérôme Lambert, Xavier Leleu, Margaret Macro, Frédérique Orsini-Piocelle, Murielle Roussel, Anne‐Marie Stoppa, Niels W.C.J. van de Donk, Soraya Wuillème, Annemiek Broijl, Cyrille Touzeau, Mourad Tiab, Jean‐Pierre Marolleau, Nathalie Meuleman, Marie‐Christiane Vekemans, Matthijs Westerman, Saskia K. Klein, Mark‐David Levin, Fritz Offner, Martine Escoffre‐Barbe, Jean‐Richard Eveillard, Réda Garidi, Tahamtan Ahmadi, Maria Krevvata, Ke Zhang, Carla de Boer, Sanjay Vara, Tobias Kampfenkel, Véronique Vanquickelberghe, Jessica Vermeulen, Hervé Avet‐Loiseau, Pieter Sonneveld - The Lancet Oncology 2021 被引用: 175
- Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma
著者: Meletios Α. Dimopoulos, Dominik Dytfeld, Sebastian Grosicki, Philippe Moreau, Naoki Takezako, Mitsuo Hori, Xavier Leleu, Richard LeBlanc, Kenshi Suzuki, Marc S. Raab, Paul G. Richardson, Mihaela Popa McKiver, Ying-Ming Jou, Suresh G. Shelat, Michael Robbins, Brian T. Rafferty, Jesús F. San Miguel - New England Journal of Medicine 2018 被引用: 535
- Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study
著者: Saad Z. Usmani, Hang Quach, María‐Victoria Mateos, Ola Landgren, Xavier Leleu, David S. Siegel, Katja Weisel, Xiaomei Shu, Chuang Li, Meletios Α. Dimopoulos - Blood Advances 2023 被引用: 94
